This study describes non-invasive photoacoustic imaging to detect and monitor the growth of conjunctival melanomas in vivo. Conjunctival melanomas were induced by injection of melanotic B16F10 cells into the subconjunctival space in syngeneic albino C57BL/6 mice. Non-invasive in vivo photoacoustic tomography was performed before, and after tumor induction up to 2 weeks. Spectral unmixing was performed to determine the location and to assess the distribution of melanin. The melanin photoacoustic signal intensity was quantified from the tumor-bearing and control eyes at all timepoints. For postmortem validation, total tumor and melanotic tumor volumes were measured using H&E stained tumor sections and were compared to in vivo photoacoustic imaging measurements. Photoacoustic imaging non-invasively detected eyes bearing conjunctival tumors of varying sizes. The melanin signal was detected as early as immediately following injection of melanotic tumor cells. Changes in tumor size over time were assessed with changes in the volume and intensity of the melanin signal. Four growing tumors and one regressing tumor were observed. Three tumors without significant change in signal intensity over time were observed, showing variable growth. Photoacoustic melanin signal on the last day of in vivo imaging correlated with postmortem total tumor volume (R 2 = 0.81) and melanotic tumor volume (R 2 = 0.80). The results of our study show that actively growing conjunctival melanomas can be quantified in a non-invasive manner using in vivo photoacoustic tomography. The photoacoustic melanin signal intensity correlated with total and melanotic tumor volume. This novel in vivo imaging platform may help to assess new treatment modalities to manage ocular tumors.
Introduction
Conjunctival melanoma is the second most common eye cancer in adults, with an annual incidence of up to 0.8 cases per million (Isager et al., 2005; Triay et al., 2009; Tuomaala et al., 2002; Wong et al., 2014; Yu et al., 2003) , and increasing (Triay et al., 2009; Tuomaala et al., 2002; Yu et al., 2003) . It is a potentially fatal malignancy, with a mortality rate of 22-38% at 10 years (Missotten et al., 2005; Paridaens et al., 1994; Tuomaala et al., 2002; Werschnik and Lommatzsch, 2002) .
The current diagnosis of conjunctival melanoma is based on clinical examination, with histopathological evaluation of excisional biopsy if malignancy is suspected (Wong et al., 2014) . Imaging modalities enabling the assessment of tumor size and the margins in a non-invasive manner may be helpful to monitor the tumor before and after treatment (Vora et al., 2017) . Current imaging modalities, such as anterior segment optical coherence tomography (AS-OCT) and ultrasound biomicroscopy (UBM), have previously been used to image and evaluate margins and thickness of conjunctival melanomas, especially superficial https://doi.org/10.1016/j.exer.2018.11.014 Received 13 August 2018; Received in revised form 21 October 2018; Accepted 13 November 2018 T ones. However, they have some limitations. AS-OCT is unable to visualize posterior margins of larger and more pigmented tumors due to light attenuation and optical shadowing (Bianciotto et al., 2011; Janssens et al., 2016) . UBM uses high-frequency transducers, and so has a limited penetration depth of 4-5 mm (Janssens et al., 2016) . Lower frequency transducers can be used to image deeper. However, ultrasound imaging systems can still suffer from reduced contrast, as differences in acoustic impedance between different tissues can be low (Beard, 2011; Dummer et al., 1995; Y. Wang et al., 2016) . Hence, novel imaging modalities are needed for non-invasive detection and evaluation of this potentially fatal disease.
Photoacoustic imaging is a recently developed imaging modality that combines the high contrast of optical imaging with the high spatial resolution of ultrasound (Kim et al., 2010b; L. V. Wang, 2009 ; L. V. Wang and Hu, 2012) . This technique allows imaging several centimeters in depth by way of acoustic waves generated in response to the absorption of pulsed laser light (L. V. Wang and Hu, 2012; L. V. Wang and Yao, 2016) . The photoacoustic effect depends on the chromophores in the tissue such as melanin.
Photoacoustic imaging has been used for the evaluation of skin melanomas (Kim et al., 2010a; Oh et al., 2006; Y. Wang et al., 2016; Zhou et al., 2015 Zhou et al., , 2014 , and has recently shown promise for clinical evaluation of tumors prior to surgical excision (Breathnach et al., 2018; Chuah et al., 2017; Zhou et al., 2017) . To date, no studies have evaluated photoacoustic imaging for detection and monitoring of conjunctival melanomas. For this study, we developed a model of conjunctival melanoma in albino mice, by modifying a model previously described in pigmented mice (Schlereth et al., 2015) . We aim, in this study, to evaluate and characterize conjunctival melanomas and their growth in this experimental model by in vivo photoacoustic tomography.
Material and methods

Cell culture
B16F10 melanoma cells (ATCC, VA, USA) were maintained in Dulbecco's Modified Eagle Medium (Thermo Fisher Scientific, ON, Canada) supplemented with 10% fetal bovine serum (Thermo Fisher Scientific), 50U/mL penicillin-streptomycin (Thermo Fisher Scientific) and 200 μM L-glutamine (Thermo Fisher Scientific). Cells were cultivated in T-75 tissue culture flasks (Sarstedt, QC, Canada) at 37°C and 5% CO 2 humidity. To harvest cells, cultures were treated with 0.25% trypsin-EDTA (Thermo Fisher Scientific), suspended in 1X phosphatebuffered saline (PBS), counted with a hemocytometer (Thermo Fisher Scientific) and re-suspended in 1X PBS at the desired cell concentration. Cell solutions were kept on ice until use.
Photoacoustic imager
The photoacoustic tomography used in the present studies was the MSOT InVision128 (iThera Medical, Munich, Germany). The detailed setup of this system has been previously described . Briefly, an Nd:YAG laser (1064/532 nm) coupled to a tunable optical parametric oscillator provides excitation light with 8 ns pulse length, 10 Hz pulse frequency and peak pulse energy of 100 mJ at 730 nm. Excitation light is distributed from 10 slit-shaped fiber light outlets, arranged so that the specimen is illuminated from 360°. Ultrasound signals generated by the photoacoustic effect are detected using a concave array of 128 element, 5 MHz ultrasound transducers, with a coverage angle of 270°. For imaging, specimens are placed within specialized holders, submerged into a chamber partially filled with water maintained at 34°C and moved across the ultrasound transducers using a motorized stage to capture 2D cross-sectional images at multiple positions along the z-axis. For in vitro imaging, specimens are placed within the specialized phantom holder and submerged directly into the water chamber. For in vivo imaging, animals were first wrapped in a 7 μm thin polyethylene film (iThera Medical Inc.) within the dedicated animal holder to prevent contact with water in the imaging chamber. A thin layer of clear ultrasound gel (Aquasonic Clear, Parker Laboratories, NJ, USA) was applied to provide acoustic coupling. Anesthesia and oxygen were provided by a nose cone within the animal holder.
In vitro photoacoustic characterization of B16F10 melanoma cells
To characterize the photoacoustic spectrum of B16F10 cells, and determine the relationship between cell density and photoacoustic signal, cells at various densities (3600, 1800, 900, 450, 225, 112.5, 56.3, 28.1, 14.1, 7 .0 cells/μl) were placed in tissue-mimicking phantoms and imaged using the photoacoustic imager.
Phantoms were made using a modified protocol from Dean-Ben et al. (2011) . Seven hundred and fifty mg of agar (Sigma-Aldrich, MO, USA) was dissolved in 50 mL of deionized water and heated in a microwave until boiling. Two and a half mL of warm Intralipid (20%, Sigma Aldrich, MO, USA) was added to provide optical scattering representative of tissues, creating a 1.5% agar, 1% intralipid solution. The mixture was poured into a cylindrical mold of 18 mm in diameter, obtained by modifying a 20 mL syringe (Becton, Dickinson and Company, NJ, USA). Two transparent 3 mm diameter plastic straws (London Bar and Kitchen, Watford, United Kingdom) were placed symmetrically into the center of the phantom. Once cooled and solidified, the agarIntralipid phantom was removed from the external mold and straws were carefully withdrawn. The B16F10 cell suspension was placed in a clear plastic straw, sealed on both ends with transparent glue (Mastercraft, TN, USA) heated with a glue gun (Mastercraft). The straw containing each cell density was imaged in the phantom, next to a control straw containing PBS, at 6 different positions in 0.3 mm steps along the z-axis. At each depth, the wavelength was scanned from 680 to 980 nm in 5 nm steps, and 4 frames were averaged per wavelength.
Commercial ViewMSOT software (Ver3.8, iThera Medical) was used to process and analyze photoacoustic data at 680, 700, 715, 730, 760, 800, 850 and 900 nm wavelengths. Photoacoustic images were reconstructed using a back-projection algorithm. To obtain the spectra of B16F10 cells, a circular region of interest (ROI) was drawn at the 6 o'clock position within the cell sample at a single reconstructed photoacoustic image for each cell density. The mean pixel intensities (MPIs) at each wavelength within the ROI were obtained. MPIs were expressed as a percentage of the highest intensity at each cell density, and plotted against wavelength to obtain the spectra of B16F10 cells. To determine the relationship between cell density and photoacoustic signal, reconstructed photoacoustic images were spectrally unmixed by linear regression (Tzoumas et al., 2014) , with the absorption spectra for melanin as input. These images were then visualized in 3D, and cylindric volumes of interest of approximately 0.15 mm 3 in size, were drawn around the B16F10 and PBS samples at the 6 o'clock position of the straw. The MPI and standard deviation, and summed pixel intensity (SPI) of the melanin signal (MSOT a.u.) in each VOI was obtained and plotted against B16F10 cell density, and a linear regression analysis was performed. Quantification of the melanin signal revealed that, at cell densities < 450 cells/μl, the MPI was less than 3 times the standard deviation of the highest MPI from the control sample (0.31 ± 0.11 MSOT a.u.), so that 450 cells/μl was considered as the detection threshold (Song et al., 2008) .
In vivo photoacoustic tomography (PAT)
All in vivo experiments were approved by the institutional animal care committee and were performed in accordance with the guidelines of the National Institutes of Health guide for the care and use of laboratory animals. For tumor induction, we injected B16F10 cells, derived from mouse cutaneous melanoma and expressing melanin, into the subconjunctival space. A similar technique was previously described in pigmented mice (Schlereth et al., 2015) . Fifteen 3-4-monthold female albino B6(Cg)-Tyr c−2J /J mice (Jackson Laboratories, ME, USA) were studied. Mice were kept on a 12 h light/dark cycle and given ad libitum access to food and water.
Tumor induction
To induce the conjunctival melanoma, subconjunctival injections (n = 15) of B16F10 cells were performed under general anesthesia with 2% isoflurane in 100% O 2 and using a dissecting microscope (Carl Zeiss, Oberkochen, Germany). Five microliters of B16F10 cells (750 cells/μl) suspended in 1X PBS were injected into the temporal subconjunctival space of the right eye and 2 mm from the limbus using a 10 μl syringe with a 33G needle (Hamilton Company, NV, USA). Successful subconjunctival injection was confirmed with the formation of a bolus underneath the conjunctiva, and observation of no or minimal leakage of tumor cells under a dissecting microscope. Following injection, mice were placed in a clean cage atop a warming pad (E-Z Anesthesia, PA, USA) for recovery for 20 min before returned to their home cages.
Seven out of the tumor-injected 15 mice showed no evidence of tumor cells in clinical photographs or by photoacoustic images by day 3 after injection, and were excluded from the study.
Photoacoustic tomography
In vivo photoacoustic imaging was performed one day before injection, and on day 1 (right after injection), 3, 5, 7, 10, 12 (n = 8), 15 (n = 7) and 16 (n = 1). Mice were anesthetized with 2% isoflurane in 100% O 2 . Clear eye gel (GenTeal, Novartis, Switzerland) was topically applied to keep eyes moist. In preparation for photoacoustic imaging, hair from the head and neck was shaved using a shaver (Wahl, IL, USA) and the remaining hair was removed using a depilatory cream (Nair, Church and Dwight Co., NJ, USA).
Photoacoustic imaging was performed to capture a series of crosssectional images through the head in 0.3 mm steps at each of 680, 700, 715, 730, 760, 800, 850 and 900 nm wavelengths. Ten frames at each wavelength were averaged, requiring approximately 7-9 min to scan all wavelengths and positions. After each imaging session, the mice were recovered in a clean cage placed atop a warming pad before being returned to their home cage and provided free access to food and water.
Signal visualization and quantification
The photoacoustic images were reconstructed with the backprojection algorithm (ViewMSOT, iThera Medical). To visualize the melanin signal within the conjunctival tumors, an Adaptive Matched Filter (AMF) algorithm was used (Tzoumas et al., 2016) . 3D visualizations of AMF-unmixed photoacoustic images were generated, and circular VOIs were drawn around the melanin signal in the tumor-bearing eyes and a similarly-sized VOI was drawn in the control eye. For each mouse, the size of the VOIs was kept consistent across all days of imaging. However, due to variations in tumor size, the VOIs were different between animals.
For quantification of the melanin signal, the coordinates of the VOIs generated in AMF-unmixed images were transferred to 3D visualizations of photoacoustic images spectrally unmixed for melanin and oxygenated and deoxygenated hemoglobin using the linear regression algorithm (Tzoumas et al., 2014) . The SPI of the melanin signal was extracted from each VOI.
Statistical analysis
For each mouse, the SPI of the melanin signal in the tumor-bearing and control eyes for each imaging day was obtained. The data were normalized by expressing SPIs in the tumor-bearing and control eyes as a percentage of the highest value found in the former across the imaging days for each mouse. This was done in order to allow for comparisons between mice, as the VOIs varied between mice due to varying tumor sizes. The resulting normalized data was plotted against imaging day and linear regression was performed. The slopes of the regression lines were averaged and compared between the VOIs in the tumorbearing and control eyes using paired two-tailed t-tests (GraphPad Prism, version 7.0c, GraphPad Software Inc., CA, USA).
All mice except one (ID: M8) had a photoacoustic imaging timepoint on the same day as the day of sacrifice. Mouse M8 died on Day 16 after tumor induction, but the last photoacoustic imaging timepoint obtained was on Day 15. Therefore, only PAT imaging over time was used for this mouse in this study.
Histopathological correlation 2.5.1. Tissue preparation, sectioning & staining
The mice were sacrificed by intracardiac injection of T-61 (Merck, Kenilworth, NJ, USA) at 15 (n = 6) and 16 (n = 1) days after tumor induction. Whole head specimens were collected and immersion fixed in 2% PFA overnight (16 h) at 4°C. Following fixation, the intact specimens were washed with 1X PBS and cryoprotected by immersion in 10% sucrose solution for 24 h at 4°C once and in 20% sucrose solutions for 24 h at 4°C twice. Fixed and cryoprotected eyes were exenterated, and then frozen in 2-methylbutane (Thermo Fisher Scientific) cooled with dry ice. The specimens were embedded in Tissue-Tek O.C.T compound (Sakura Finetek, CA, USA) and serially sectioned at 20 μm thickness with a cryostat (CM 1900, Leica Biosystems, ON, Canada). Selected sections were H&E stained using the Leica ST5010 Autostainer XL (Leica).
Light microscopy and hyperspectral imaging
H&E stained sections were imaged using a 10x 0.30NA UPlanFI objective on an upright microscope (BX51, Olympus, Tokyo, Japan). Multiple color images, spanning the entire tumor, were captured with a CCD camera (Microfire, Optronics, CA, USA) using MATLAB's Image Acquisition Toolbox v4.5 (TheMathWorks Inc, MA, USA). Using the Seamless Mosaic Toolbox within ENVI v5.4 (Harris Corporation, CO, USA), overlapping co-registered images for each section were stitched into a single image and saved as a TIFF file.
In order to visualize melanin distribution in the tumors, bright-field images of select H&E stained sections were taken with a 10x 0.3NA UPlanFI objective and an Image Mapping Spectrometer (IMS) snapshot hyperspectral scientific CMOS camera (Bedard et al., 2012) (pco.edge.5.5, PCO AG, Kelheim, Germany) attached to the Olympus BX51 microscope with a 100W halogen light source. The IMS images were collected at wavelengths from 528 to 836 nm with 4 nm steps. A flatfield correction was applied to all images (Seibert et al., 1998) . Overlapping co-registered images for each section were stitched in ENVI v5.4. Stitched images were visualized at a single wavelength (760 nm), and a logarithmic histogram stretch was applied. A pseudocolor image represented by 528, 548 and 636 nm wavelengths was also generated for each section. All images were exported as TIFF files.
Tumor volume estimation
To determine the total tumor volume, 5-6 H&E stained sections, including the first, last and largest, were selected for each mouse. The Cavalieri Estimator probe within the Stereo Investigator software (ver8.27, MBF Bioscience, VT, USA) was used to find the surface tumor area in each section. These were then multiplied by the section thickness (20 μm) and inter-section distance to estimate total tumor volume.
To determine the melanotic tumor volume, three H&E stained sections, including the largest tumor section and two equally distanced adjacent sections, were selected for each mouse and imaged with IMS. For each section, the Cavalieri estimator was used to measure the surface area of a) the melanin signal in the 760 nm image, and b) the entire tumor in the pseudocolor image. For each section, the surface area of the melanin signal was divided by the total surface area. For each mouse, this ratio was averaged across the 3 sections, and multiplied by the previously determined total tumor volume to estimate the melanotic tumor volume.
Two animals were excluded from the volume analyses. M8 was excluded due to death prior to the last photoacoustic imaging timepoint (see above). M12 was excluded due to an insufficient number of serial sections collected.
Results
In vitro
Photoacoustic imaging in the agar phantom (Fig. 1A) showed strong melanin signal from the tumor cells but no detectable signal in the PBS control (Fig. 1B) . Quantification of the melanin signal showed a lower detection limit of 450 cells/μl. The melanin signal intensity increased with cell density up to the maximum concentration used of 3600 cells/ μl. Both the mean pixel intensity (Fig. 1C , R 2 = 0.99) and summed pixel intensity (Fig. 1D , R 2 = 0.99) showed linear relationships with cell density. Similar photoacoustic spectra were noted at all cell densities (Fig. 1E) , and the signal decreased linearly from 680 to 850 nm.
In vivo photoacoustic tumor detection
All tumors were seen distinctly observed in the temporal subconjunctival space of the tumor-bearing eyes (n = 8, Fig. 2A ) compared to the surrounding normal tissues (Fig. 2B) . Histologic sections confirmed the presence of temporally-located tumor cells between the overlying conjunctiva and underlying sclera ( Fig. 2C and D) . Crosssectional photoacoustic images of the whole mouse head showed a strong melanin signal in the region of the conjunctival melanomas (Fig. 3) .
In vivo photoacoustic monitoring of conjunctival melanoma over time
Following tumor cell injection, conjunctival melanomas showed growth in 4 cases (Fig. 4A ) and variable growth in 3 cases. In one case, tumor regression was also seen (Fig. 4B) . Immediately following injection of tumor cells, the photoacoustic melanin signal was detected (Fig. 5A) . In those tumors showing growth, the distribution of this signal increased over time (Fig. 5B-D) . Quantitative analysis showed higher photoacoustic signal intensities in the tumor-bearing eyes compared to the background signal observed in the control eyes on days 1 (n = 4), 3 (n = 1), 5, 7 (n = 3), 10, 12, 15 (n = 4) and 16 (n = 1), and increased over time (Fig. 5E ). The average slope of signal intensity with time was positive and significantly steeper in the right eye compared to the control eye (4.49 ± 0.638 vs 0.167 ± 0.173, respectively; P = 0.0008) (Fig. 5F ).
Tumors with variable growth (n = 3) showed fluctuating photoacoustic melanin signal distribution (Fig. 6A-D) . Quantified photoacoustic signal showed higher intensities in the tumor-bearing eyes compared to the control eyes on all imaging days (n = 3), and were fluctuating over time (Fig. 6E) . The average slope of signal intensity with time was negative in the tumor-bearing eyes but this was not statistically different from the control eyes (−1.88 ± 0.261 vs 0.713 ± 0.887, respectively; P = 0.056) (Fig. 6F) .
In the tumor that showed regression, the photoacoustic melanin signal distribution was seen to decrease over time (Fig. 7A-D) . Quantified photoacoustic signal showed higher intensities in the tumor- bearing eye compared to the control, and decreased over time. The signal intensity with time slope was negative in the right eye, and steeper than that of the slope in the control eye (−4.45 vs −0.190, respectively) (Fig. 7F) .
Histopathological validation of in vivo photoacoustic tomography results
H&E-stained sections clearly showed the tumor and surrounding orbital and eye tissue. Transmission microscopy images at 760 nm of the same sections (Fig. 8A ) detected the melanin distribution as an area of signal contrast (Fig. 8B ) and the photoacoustic melanin signal was seen in the corresponding region (Fig. 8C) . A linear relationship was found between summed photoacoustic melanin signal and the total tumor volume ( (Table 1) .
Discussion
To our knowledge this is the first study to characterize and evaluate conjunctival melanomas using non-invasive in vivo photoacoustic imaging. Photoacoustic tomography with spectral unmixing of the melanin signal specifically detected conjunctival melanomas. In vivo photoacoustic tomography allowed quantitative assessment of the changes in tumor size over time.
Specific and sensitive detection of the melanin signal was achieved in our study. In vitro phantom studies revealed a detection limit of 450 B16F10 cells/μl is within the reported range of 5-6250 B16F10 cells/μl (Lavaud et al., 2017; Neuschmelting et al., 2016a Neuschmelting et al., , 2016b Xiang et al., 2014) . The detection limit will change with factors such as the photoacoustic imaging setup and phantoms used, the depths at which samples were embedded and imaged, the ROI selection and the differences in levels of melanin expression in cultured melanoma cells. The photoacoustic spectrum at cell densities above this limit decreased with increasing wavelength up to 850 nm, similar to the absorption spectrum of melanin (Zonios et al., 2008) , which indicates that melanin is the predominant source of contrast in the near-infrared wavelength range used. The small increase at 900 nm was likely due to water that has a weak absorption band from 900 to 1150 nm, peaking at 970 nm (Petty and Curcio, 1951) .
This sensitive and specific detection of endogenous melanin content of tumor cells by photoacoustic imaging allowed for early detection of conjunctival tumors. Tumors were detected even just after injection into the subconjunctival space (5 μl of 750 cells/μl, 3750 cells total). This is consistent with previous studies, which detected B16 melanomas in the brain (Neuschmelting et al., 2016a; Staley et al., 2010) and skin (Y. Zhou et al., 2015) in mice within the first week following tumor induction using melanin detection by photoacoustic imaging. The early detection enabled by photoacoustic imaging in our study allowed for frequent longitudinal monitoring of tumor size. Furthermore, histopathological validation showed that tumors as small as 0.0029 mm 3 were easily detected and visualized with melanin detection using photoacoustic imaging. The syngeneic conjunctival melanoma mouse model developed in our study produced heavily pigmented tumors in immunocompetent mice that are otherwise devoid of melanin pigment. Albino animals are frequently used in photoacoustic imaging studies, and provided several advantages here. First, chemical depilation as required for photoacoustic imaging induces hair follicles to enter the anagen phase in C57BL/6 mice, which is accompanied by pigment production in the hair follicles (Sundberg and Silva, 2012) and temporal variations in skin pigmentation that can affect quantitative optical imaging (Curtis et al., 2010; Kwon and Sevick-Muraca, 2017) . This problem was avoided in our study with the use of albino mice. Second, the optimized melanin distribution in the tumor, combined with the high optical absorption of melanin in the near-infrared range (Yao and Wang, 2013) , provided high contrast detection of conjunctival tumors, mainly due to the decreased background signal from melanin observed in the surrounding normal tissue. In humans, the conjunctiva is a thin and largely transparent layer, the sclera absorbs minimally at near-infrared wavelengths (Bashkatov et al., 2010) , and 70-80% of conjunctival melanomas have some degree of pigmentation (Shields et al., 2000 . Hence, a similar photoacoustic contrast may be expected between conjunctival tumors and surrounding normal eye tissue, especially with the use of higher resolution imaging systems which can avoid imaging depths that include contributions from the underlying pigmented ocular structures. However, the degree and pattern of pigmentation of conjunctival tumors can be highly variable (Shields et al., 2000 , unlike the more controlled mouse model used here. As such, studies in pigmented mice, and in mouse models with varying degrees of conjunctival tumor pigmentation, may be useful to further evaluate the clinical utility of this imaging system.
The specific features of the photoacoustic imager and imaging parameters used also contributed to the sensitive and specific detection achieved in our study. In the photoacoustic imager used here, the mouse was evenly illuminated with a ring-shaped strip of excitation light covering the entire body, and generated ultrasound signals were detected by ultrasound transducers organized in a 270-degree concave array. This allowed for both the generation and detection of melanin signals at multiple angles, and may have enhanced the detection of small tumors in our study. Photoacoustic imaging with multiple nearinfrared wavelengths spanning the maxima, minima and inflection points of the melanin, oxygenated and deoxygenated hemoglobin absorption spectra further enhanced tumor detection, as the signal contributions from melanin could be separated from those of oxy-and deoxy-hemoglobin.
For small tumors, the melanin photoacoustic signal was found throughout the periphery and the center of the tumor, but in larger tumors the melanin signal was missing from the center. This was likely due to a combination of attenuation of light by the strong absorption of melanin in the periphery, and heterogenous melanin expression within the tumor, as in some cases, transmission imaging showed that melanin content was not evenly distributed throughout the entire tumor. While the melanin signal in the periphery is still sufficient to detect the tumor and most of its margins, and evaluate any changes in size qualitatively using photoacoustic imaging, quantitative analysis may be compromised, as the melanin signal intensity in larger tumors will not reflect content from the entire mass and changes over time may be underestimated. Another factor complicating longitudinal photoacoustic monitoring of tumor growth is the fact that melanin content in B16F10 cells can change during differentiation and in response to various intrinsic and extrinsic factors (Kim et al., 2008; Kosano et al., 2000; Martínez-Esparza et al., 1998) , so that increased or decreased melanin signal may not reflect only changing tumor size but also changing melanin expression. These limitations may be overcome by the use of a combined photoacoustic and ultrasound system: co-registered ultrasound images would allow visualization of the center of large tumors and help to evaluate the contribution of changes in tumor size and melanin expression.
Collectively, our data suggest that detection of melanin by photoacoustic imaging shows promise for evaluation and monitoring of mouse conjunctival melanomas and may help in response evaluation of novel treatments. It may also be useful clinically for non-invasive detection of conjunctival melanoma. Thus, in earlier studies in preclinical mouse models of cutaneous melanoma, melanin within pigmented tumors provided strong contrast compared to surrounding skin tissue, clearly visualized small, early-stage tumors (Y. , which can be difficult to detect with ultrasound, and enabled accurate measurements of tumor thickness (Zhou et al., 2015 (Zhou et al., , 2014 and volume (Zhou et al., 2015) . The success of these pre-clinical studies has prompted recent clinical investigations of photoacoustic imaging for detection of cutaneous melanomas, using handheld probes (Breathnach et al., 2018; Chuah et al., 2017; Zhou et al., 2017) . In the eye, detection of melanin by photoacoustic imaging has previously been used to detect anterior and posterior segment structures in vivo in rodent models (Jiao et al., 2010; Liu et al., 2012 Liu et al., , 2015 and ex-vivo in pig eyes (Kong et al., 2009; la Zerda et al., 2010; Nam and Emelianov, 2014; Silverman et al., 2010) . The melanin signal provided sharper images with higher contrast of the iris, ciliary body, choroid and retinal pigment epithelium compared to ultrasound alone (Kong et al., 2009; Nam and Emelianov, 2014; Silverman et al., 2010) . Recently, Xu et al. (2017) demonstrated the capabilities of a parallel ultrasound and photoacoustic imaging system utilizing near-infrared wavelengths to detect uveal melanomas by their melanin content in intact ex-vivo human eye specimens. These studies highlight the potential of photoacoustic imaging to provide high contrast detection of conjunctival melanomas and to aid in the diagnosis and evaluation of tumor size and margins for treatment planning prior to surgical excision. However, the clinical translation will require the use of photoacoustic light laser intensities within ocular safety limits, a handheld ultrasound transducer that can detect ultrasound signals from multiple angles, and a highspeed system to minimize motion artifacts due to eye movements (Liu and Zhang, 2016) .
In conclusion, the dynamic growth of conjunctival melanomas was assessed in a non-invasive manner using photoacoustic tomography in vivo in a live albino mouse model. This novel imaging platform may be of value in the pre-clinical assessment of new treatments for conjunctival melanoma. 
